Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medication Abortion topic
No spam. Unsubscribe anytime.
Assembly passes bill shielding existing medication-abortion drugs from state penalties if federal labeling changes
Summary
On Jan. 27 the Assembly passed legislation (Assembly 9217) to protect prescribing and dispensing of existing medication-abortion drugs, including mifepristone and misoprostol, from state criminal and licensing penalties if FDA approvals or labels change; the bill passed 94–47.
The New York State Assembly on Jan. 27 approved a bill aimed at protecting health professionals who prescribe or dispense medication-abortion drugs already in pharmacies if federal regulatory labels change. On a party-line recorded vote the chamber approved the measure 94–47, and the bill takes effect immediately.
Sponsor Miss Pollan said the measure would “ensure that state law did not prohibit the prescribing or dispensing of mifepristone or any drug used for medication abortion solely because it is no longer approved by the Federal Food and Drug Administration.” She told colleagues the bill focuses on existing drugs already on pharmacy shelves and that the key change is in section 3 of the measure, which amends the Criminal Diversion Act and related education-law provisions to protect prescribers and dispensers from professional or criminal penalties tied only to a federal label change.
Opponents described the measure as premature. Miss Walsh urged caution, saying lawmakers were “putting the cart before the horse” while a federal review of mifepristone was reportedly underway. Walsh and others pressed the sponsor to confirm the bill covers both mifepristone and misoprostol and to explain how state protections would operate if the FDA adds REMS requirements or otherwise changes labeling.
Miss Pollan and staff told members the bill is limited to existing supplies and would not immunize future distribution decisions; she also pointed to similar statutory language New York has used previously and argued the measure is designed to protect providers and preserve medication-abortion access in the state.
Lawmakers debated technical points including the criminal penalties currently tied to diversion (which staff said range from misdemeanor to felony for repeat offenders), the possibility of a state stockpile, and whether it is appropriate for state law to adopt guidance from international bodies. Mr. Smolin asked about constitutional concerns and about relying on World Health Organization guidance; Miss Pollan noted comparable language had been used in earlier state laws.
The clerk announced the recorded vote — Ayes 94, Noes 47 — and declared the bill passed. Several members explained their votes on the floor before the tally was read.
